|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 145 USD | -1.23% |
|
-1.59% | -7.22% |
| 12:39pm | US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug | RE |
| 24/06 | US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit | RE |
April 4 (Reuters) - Johnson & Johnson said on Thursday it has recommended its shareholders to reject an unsolicited "mini-tender" offer by TRC Capital Investment Corporation for about 0.04% oits common stock.
The drugmaker said Ontario-based TRC Capital has offered to purchase up to 1 million shares of J&J's stock at a price of $151.23 per share in cash. (Reporting by Christy Santhosh in Bengaluru; Editing by Krishna Chandra Eluri)
| 1st Jan change | Capi. | |
|---|---|---|
| -7.22% | 353B | |
| +55.10% | 811B | |
| +43.62% | 640B | |
| +17.82% | 333B | |
| +8.94% | 302B | |
| +16.30% | 246B | |
| +2.41% | 225B | |
| +12.47% | 218B | |
| +8.59% | 168B | |
| -3.53% | 155B |
JOHNSON & JOHNSON 
